Third Rock Ventures Launches Ember Therapeutics with $34M

Boston-based Third Rock Ventures has unveiled a new company, Ember Therapeutics, a product-focused company that’s trying to harness breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease. Third Rock, a venture firm that helps incubate life sciences companies, has given Ember $34 million in Series A financing. PRESS RELEASE: BOSTON, Dec […]

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget